Insulet Corp at Stephens Investor Conference Transcript
Well, good morning, everyone. You're almost at lunch. Hang in there. And it's warming up outside as well. I'm Chris Cooley. I'm the Senior Medical Device Analyst here at Stephens. We greatly appreciate you being with us today here at Nashville 2019, and we're also honored today to have a part of our device track, Insulet Corporation. And we've got a full lineup here for you. We have Wayde McMillan, the company's Executive Vice President and Chief Financial Officer and Treasurer. We have Deb Gordon, the Vice President of Investor Relations and Corporate Communications. And we also have Lauren Budden here with us today, too, the Chief Accounting Officer. So we can get all of our questions answered that, I guess, you 2 can't answer.
But we greatly appreciate you joining us here today and being a part of our event.
Questions & Answers
Let's just start off with what I think is maybe one of the most exciting aspects of the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
